Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein

Biochemistry
E L DiGiammarinoRichard W Kriwacki

Abstract

Arf is a tumor suppressor that regulates p53 function and is a frequent target for loss in human cancers. Through two novel mechanisms, Arf inhibits the oncoprotein Hdm2, a negative regulator of p53. (1) Arf inhibits the E3 ubiquitin ligase activity of Hdm2 that leads to p53 degradation, and (2) Arf sequesters Hdm2 within nucleoli. These activities of Arf promote p53-mediated cell cycle arrest and apoptosis. Fundamental to these processes are interactions between Arf and Hdm2. Here we show that a peptide containing the 37 N-terminal amino acids of mouse Arf (mArfN37) localizes to nucleoli, sequesters Hdm2 within nucleoli, and causes cell cycle arrest. Circular dichroism and NMR spectroscopy show that mArfN37 is largely unstructured under aqueous conditions; however, the peptide adopts two alpha-helices (helix 1, residues 4-14; and helix 2, residues 20-29) in 2,2,2-trifluoroethanol (TFE). Each helix contains an amino acid motif that is repeated twice in mArfN37, once in each helix. The two helices, however, do not interact but are connected by an apparently flexible linker. The repeated motif contains Arg residues spaced by a hydrophobic segment that may be involved in Hdm2 recognition and binding. The RRPR nucleolar localizatio...Continue Reading

References

Sep 1, 1974·Journal of Bacteriology·F C NeidhardtD F Smith
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi

❮ Previous
Next ❯

Citations

Feb 13, 2003·The Journal of Biological Chemistry·Sergio MenéndezSonia Lain
Feb 18, 2011·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Nicholas L Adkins, Philippe T Georgel
Feb 6, 2018·Chembiochem : a European Journal of Chemical Biology·Ferenc Zsila
Aug 8, 2020·Biomolecules·Jinho SeoJaewhan Song
Aug 12, 2005·Journal of Molecular Recognition : JMR·Vladimir N UverskyA Keith Dunker
Dec 12, 2001·Molecular and Cellular Biology·Chandrashekhar KorgaonkarDawn E Quelle
Mar 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Diana M MitreaRichard W Kriwacki
Oct 16, 2004·Molecular and Cellular Biology·Suzanne N BradyJason D Weber
Nov 8, 2008·Molecular Biotechnology·Andrej SavchenkoElena Kashuba
Dec 29, 2017·The FEBS Journal·Enrico LuchinatLuca Federici
Jul 16, 2020·International Journal of Molecular Sciences·Ilaria CelaLuca Federici
Jan 23, 2015·Protein Science : a Publication of the Protein Society·Yugang ZhangZhirong Liu
Sep 27, 2006·Proteins·Mi-Kyung YoonByong-Seok Choi
Jun 21, 2008·Molecular Cancer Therapeutics·Eisaku KondoTadashi Yoshino
Oct 7, 2006·Journal of Proteome Research·Charles A GaleaRichard W Kriwacki
Mar 1, 2016·Chemical Reviews·Veronika CsizmokJulie D Forman-Kay
Mar 13, 2003·Journal of the American Chemical Society·Brian BothnerRichard W Kriwacki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Protein Science : a Publication of the Protein Society
Grace W YuMark Bycroft
Proceedings of the National Academy of Sciences of the United States of America
Grace W YuAlan R Fersht
Molecular Cancer Research : MCR
Tomoo Iwakuma, Guillermina Lozano
© 2021 Meta ULC. All rights reserved